Former US Vice President Al Gore visits Novo Nordisk in Denmark  

2007.03.15
Hot on the heels of President George W. Bush's visit to the Danish-owned Novozymes' facility in North Carolina, former US Vice President Al Gore visited Novo Nordisk in Denmark on Tuesday
Hot on the heels of President George W. Bush's visit to Danish-owned Novozymes' research and production enzyme facility in North Carolina, former US Vice President Al Gore visited Novo Nordisk in Denmark on Tuesday to learn about how the world's leading company in diabetes care is addressing climate change challenges, and to share ideas on how to halt global warming. The visit reflects Al Gore's recognition of the work being carried out by Novo Nordisk on sustainability and environmental issues.
 
Novo Nordisk has set the target of a 10% reduction in the company's CO2 emissions by 2014 compared to 2004. The target is part of an agreement with WWF that has made Novo Nordisk one of twelve global leaders in the Climate Savers programme. Lise Kingo, executive vice president and host of the meeting with Al Gore says: "We believe that our drive to reduce CO2 emissions is an obligation and also an opportunity to be better prepared for a carbon constrained future and less vulnerable to fluctuation in energy prices."
 
Novo Nordisk is a healthcare company and a world leader in diabetes care. The company also has a leading position in haemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs more than 23,600 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. The news was reported by Business.dk and on the Novo Nordisk website.
 
Link > Novo Nordisk  

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×